NNVC compared with CTXR: revenue, margins and what each company keeps, and the suppliers and customers both name

NNVCNanoviricides, Inc.

Mkt capRevenueRevenue

CTXRCitius Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

NNVCNanoviricides, Inc.

CTXRCitius Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

NNVC

No earnings history for NNVC.

CTXR2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 27 '26—▲+11.62%—

Q3 FY26±41.1%▼−25.62%×0.62

= impliedNNVC realized, solidCTXR realized, hatchedOne scale, both sides: full bar = 42%× = |realized| ÷ impliedSource: market data

NNVCNanoviricides, Inc.

1.33▲+3.10%· post 1.33

Mkt cap$33.7MRevenue—

CTXRCitius Pharmaceuticals, Inc.

0.55▼−1.08%· post 0.55

ClosedNov 6 '26

Mkt cap$15.0MRevenue$1MQ3 FY26

Compare

ClosedNov 6 '26

NNVCNanoviricides, Inc.

CTXRCitius Pharmaceuticals, Inc.

1.33▲+3.10%post 1.33

Price

0.55▼−1.08%post 0.55

$33.7M

Mkt cap

$15.0M

—

Revenue

$1MQ3 FY26

NNVC1.33▲+3.10%vsCTXR0.55▼−1.08%ClosedNov 6 '26